PennyStocks101: 5 Hot Stocks in Motion - AspenBio Pharma, Inc., Cytori Therapeutics, Facebook Inc., Accenture Plc., and Research In Motion Limited
Linkedin

PennyStocks101: 5 Hot Stocks in Motion - AspenBio Pharma, Inc., Cytori Therapeutics, Facebook Inc., Accenture Plc., and Research In Motion Limited

Madrid : Spain | Sep 28, 2012 at 2:58 PM PDT
Source: PRWeb
XX XX
Views: Pending
 

The US leader in microcap breakouts, offers a high quality stocks alert newsletter to investors looking for the best breakout stocks around. PennyStocks101 reports 5 active stocks on Friday: AspenBio Pharma, Inc., Cytori Therapeutics, Facebook Inc., Accenture Plc., and Research In Motion Limited

The market saw even more losses on Friday as a positive consumer spending report from August indicated that spending was only up due to higher gas prices. Continued worries over Spain are also contributing to the sell off.

PennyStocks101 reports 5 stocks to put on your radar quickly. They are: AspenBio Pharma, Inc., Cytori Therapeutics, Facebook Inc., Accenture Plc., and Research In Motion Limited

1. The Company announced that it plans to initiate a pivotal study in the fourth quarter of 2012 for its blood-based appendicitis test designed to assist emergency room clinicians in ruling out acute appendicitis. The Company is moving ahead with its plans following its recent productive meeting with the U.S. Food and Drug Administration ("FDA").

You could find the next AspenBio Pharma, Inc. by subscribing to: http://www.PennyStocks101.com

2. The Company has been awarded a contract that may be valued up to $106 million by the U.S...The Company's products for users are free of charge and available on the Web, mobile Web, and mobile platforms, such as Android and iOS.

Pennystocks101.com educates and shows investors the inner workings of the volatile world of penny stocks by scouring the markets for the hottest penny stocks that look poised to break out...Sign up for the free newsletter to receive the next big report soon. Join at: http://www.PennyStocks101.com

4...For the fourth quarter, revenues before reimbursements ("net revenues") were $6.8 billion, an increase of 2 percent in U.S. dollars and 9 percent in local currency compared with the fourth quarter of fiscal 2011.

5. The Company reported better-than-expected results for its fiscal second quarter ended August 31.

Sign Up at - http://www.PennyStocks101.com for more ideas to put on your radar.

Disclosure: Pennystocks101.com and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever and we are not qualified to give financial advice. This press release may contain several forward looking statements. Please read our report and visit our website for complete risks and disclosures.

For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2012/9/prweb9957421.htm

 
  • Clear
  • Share:
  • Share
  • Clear
  • Clear
  • Clear
  • Clear
 
  • Credibility
  • Wait... Flag
 
 
Advertisement
 

More From Allvoices



Use of this site is governed by our Terms of Use Agreement and Privacy Policy.

© Allvoices, Inc. 2008-2014. All rights reserved. Powered by PulsePoint.